Spironolactone-induced inhibition of aldosterone biosynthesis in primary aldosteronism: Morphological and functional studies
- 1 December 1977
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 26 (12) , 1293-1307
- https://doi.org/10.1016/0026-0495(77)90026-9
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Diagnosis and Nomenclature of the Disorders of the Terminal Portion of the Aldosterone Biosynthetic PathwayJournal of Clinical Endocrinology & Metabolism, 1976
- Diurnal Variation of Plasma Aldosterone, Cortisol and Renin Activity in Supine ManJournal of Clinical Endocrinology & Metabolism, 1975
- Inhibition of aldosterone production in diuretic-induced hyperaldosteronism by aldosterone antagonist canrenone in manNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1974
- Volume factor in low and normal renin essential hypertension: Treatment with either spironolactone or chlorthalidoneThe American Journal of Cardiology, 1973
- On the mechanism of the inhibitory action of the spirolactone SC 9376 (aldadiene) on the production of corticosteroids in rat adrenals in vitroNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1973
- Primary reninism. Hypertension, hyperreninemia, and secondary aldosteronism due to renin-producing juxtaglomerular cell tumorsArchives of internal medicine (1960), 1972
- Spironolactone (Aldactone) Bodies: Concentric Lamellar Formations in the Adrenal Cortices of Patients Treated with SpironolactoneAmerican Journal of Clinical Pathology, 1970
- Activation of aldosterone secretion in primary aldosteronismJournal of Clinical Investigation, 1969
- Suppression of Plasma Renin Activity in Primary AldosteronismJAMA, 1964
- CYTOPLASMIC BODIES IN THE ADRENAL CORTEX OF PATIENTS TREATED WITH SPIROLACTONEThe Lancet, 1963